HOUSE BILL No. 4038

 

January 22, 2007, Introduced by Reps. Lemmons, Virgil Smith and Leland and referred to the Committee on Judiciary.

 

      A bill to amend 1978 PA 368, entitled

 

"Public health code,"

 

by amending sections 7212, 7214, 7403, and 7404 (MCL 333.7212,

 

333.7214, 333.7403, and 333.7404), sections 7212, 7403, and 7404

 

as amended by 2002 PA 710 and section 7214 as amended by 1982 PA

 

352, and by adding sections 7337, 7338, 7338a, and 7338b; and to

 

repeal acts and parts of acts.

 

THE PEOPLE OF THE STATE OF MICHIGAN ENACT:

 

 1        Sec. 7212. (1) The following controlled substances are

 

 2  included in schedule 1:

 

 3        (a) Any of the following opiates, including their isomers,

 

 4  esters, the ethers, salts, and salts of isomers, esters, and

 

 5  ethers, unless specifically excepted, when the existence of these

 


 1  isomers, esters, ethers, and salts is possible within the

 

 2  specific chemical designation:

 

 

Acetylmethadol            Difenoxin               Noracymethadol

Allylprodine              Dimenoxadol             Norlevorphanol

Alpha-acetylmethadol      Dimepheptanol           Normethadone

Alphameprodine            Dimethylthiambutene     Norpipanone

Alphamethadol             Dioxaphetyl butyrate    Phenadoxone

Benzethidine              Dipipanone              Phenampromide

Betacetylmethadol         Ethylmethylthiambutene  Phenomorphan

10 Betameprodine             Etonitazene             Phenoperidine

11 Betamethadol              Etoxeridine             Piritramide

12 Betaprodine               Furethidine             Proheptazine

13 Clonitazene               Hydroxypethidine        Properidine

14 Dextromoramide            Ketobemidone            Propiram

15 Diampromide               Levomoramide            Racemoramide

16 Diethylthiambutene        Levophenacylmorphan     Trimeperidine

17                           Morpheridine               

 

 

18        (b) Any of the following opium derivatives, their salts,

 

19  isomers, and salts of isomers, unless specifically excepted, when

 

20  the existence of these salts, isomers, and salts of isomers is

 

21  possible within the specific chemical designation:

 

 

22 Acetorphine              Drotebanol                 Morphine-N-Oxide

23 Acetyldihydrocodeine     Etorphine                  Myrophine

24 Benzylmorphine           Heroin                     Nicocodeine

25 Codeine methylbromide    Hydromorphinol             Nicomorphine

26 Codeine-N-Oxide          Methyldesorphine           Normorphine

27 Cyprenorphine            Methyldihydromorphine      Pholcodine

28 Desomorphine             Morphine methylbromide     Thebacon


Dihydromorphine          Morphine methylsulfonate  

 

 

 2        (c) Any material, compound, mixture, or preparation which

 

 3  contains any quantity of the following hallucinogenic substances,

 

 4  their salts, isomers, and salts of isomers, unless specifically

 

 5  excepted, when the existence of these salts, isomers, and salts

 

 6  of isomers is possible within the specific chemical designation:

 

 

2-Methylamino-1-phenylpropan-1-one

     Some trade and other names:

     Methcathinone

10      Cat

11      Ephedrone

12 3, 4-methylenedioxy amphetamine

13      5-methoxy-3, 4-methylenedioxy

14      amphetamine

15 3, 4, 5-trimethoxy amphetamine

16      Bufotenine

17      Some trade and other names:

18      3-(B-dimethylaminoethyl)-5 hydrozyindole

19      3-(2-dimethylaminoethyl)-5 indolol

20      N,N-dimethylserotonin; 5-hydroxy-N-dimethyltryptamine

21      Mappine

22 2, 5-Dimethoxyamphetamine

23      Some trade or other names:

24 2, 5-Dimethoxy-a-methylphenethylamine; 2,5-DMA

25 4-Bromo-2, 5-Dimethoxyamphetamine

26      Some trade or other names:

27      4-bromo-2, 5 dimethoxy-a-methylphenethylamine; 4-bromo

28      2,5-DMA

29 Diethyltryptamine


     Some trade and other names:

     N,N-Diethyltryptamine; DET

Dimethyltryptamine

     Some trade or other names:

     DMT

4-methyl-2, 5-dimethoxyamphetamine

     Some trade and other names:

     4-methyl-2, 5-dimethoxy-a-methyl-phenethylamine

     DOM, STP

10 4-methoxyamphetamine

11      Some trade or other names:

12      4-methoxy-a-methylphenethylamine; paramethoxy amphetamine;

13      PMA

14 Ibogaine

15      Some trade and other names:

16      7-Ethyl-6,6a,7,8,9,10,12,13

17      Octahydro-2-methoxy-6,9-methano-5H-

18      pyrido (1, 2:1, 2 azepino 4, 5-b) indole

19      tabernanthe iboga

20 Lysergic acid diethylamide

21 Marihuana, except as otherwise provided in subsection (2)

22   sections 7337 to 7338b

23 Mecloqualone

24 Mescaline

25 Peyote

26 N-ethyl-3 piperidyl benzilate

27 N-methyl-3 piperidyl benzilate

28 Psilocybin

29 Psilocyn

30 Thiophene analog of phencyclidine

31      Some trade or other names:


     1-(1-(2-thienyl)cyclohexyl) piperidine)

     2-thienyl analog of phencyclidine; TPCP

 

 

 3        (d) Except as provided in subsection (2), synthetic

 

 4  Synthetic equivalents of the substances contained in the plant,

 

 5  or in the resinous extractives of cannabis and synthetic

 

 6  substances, derivatives, and their isomers with similar chemical

 

 7  structure or pharmacological activity, or both, such as the

 

 8  following, are included in schedule 1:

 

 9        (i) ∆1 cis or trans tetrahydrocannabinol, and their optical

 

10  isomers.

 

11        (ii) ∆6 cis or trans tetrahydrocannabinol, and their optical

 

12  isomers.

 

13        (iii) ∆3,4, cis or trans tetrahydrocannabinol, and their

 

14  optical isomers.

 

15        (e) Compounds of structures of substances referred to in

 

16  subdivision (d), regardless of numerical designation of atomic

 

17  positions, are included.

 

18        (f) Gamma-hydroxybutyrate and any isomer, salt, or salt of

 

19  isomer of gamma-hydroxybutyrate.

 

20        Some trade and other names:

 

21        Sodium oxybate

 

22        4-hydroxybutanoic acid monosodium salt

 

23        (g) 3,4-methylenedioxymethamphetamine.

 

24        Some trade and other names:

 

25        Ecstasy

 

26        MDMA

 


 1        (2) Marihuana and the substances described in subsection (1)

 

 2  (d) and (e) in schedule 1 shall be regulated as provided in

 

 3  schedule 2, if they are dispensed in the manner provided in

 

 4  sections 7335 and 7336.

 

 5        (2) (3) For purposes of subsection (1), "isomer" includes

 

 6  the optical, position, and geometric isomers.

 

 7        Sec. 7214. The following controlled substances are included

 

 8  in schedule 2:

 

 9        (a) Any of the following substances, except those narcotic

 

10  drugs listed in other schedules, whether produced directly or

 

11  indirectly by extraction from substances of vegetable origin, or

 

12  independently by means of chemical synthesis, or by combination

 

13  of extraction and chemical synthesis:

 

14        (i) Opium and opiate, and any salt, compound, derivative, or

 

15  preparation of opium or opiate excluding nalaxone and its salts,

 

16  and excluding naltrexone and its salts, but including the

 

17  following:

 

 

18 Raw opium                        Etorphine hydrochloride

19 Opium extracts                   Hydrocodone

20 Opium Fluid-extracts             Hydromorphone

21 Powdered opium                   Metopon

22 Granulated opium                 Morphine

23 Tincture of opium                Oxycodone

24 Codeine                          Oxymorphone

25 Ethylmorphine                    Thebaine

 

 

26        (ii) A salt, compound, derivative, or preparation thereof

 

27  which is chemically equivalent to or identical with a substance


 

 1  referred to in subdivision (a), except that these substances do

 

 2  not include the isoquinoline alkaloids of opium.

 

 3        (iii) Opium poppy, poppy straw, and concentrate of poppy

 

 4  straw, the crude extract of poppy straw in either liquid, solid,

 

 5  or powder form, which contains the phenanthrene alkaloids of the

 

 6  opium poppy.

 

 7        (iv) Coca leaves and any salt, compound, derivative, or

 

 8  preparation thereof which is chemically equivalent to or

 

 9  identical with any of these substances, except that the

 

10  substances do not include decocainized coca leaves or extraction

 

11  of coca leaves which extractions do not contain cocaine or

 

12  ecgonine. The substances include cocaine, its salts,

 

13  stereoisomers, and salts of stereoisomers when the existence of

 

14  the salts, stereoisomers, and salts of stereoisomers is possible

 

15  within the specific chemical designation.

 

16        (b) Any of the following opiates, including their isomers,

 

17  esters, ethers, salts, and salts of isomers, when the existence

 

18  of these isomers, esters, ethers, and salts is possible within

 

19  the specific chemical designation:

 

20 Alphaprodine                     Fentanyl

21 Anileridine                      Isomethadone

22 Bezitramide                      Levomethorphan

23 Dihydrocodeine                   Levorphanol

24 Diphenoxylate                    Metazocine

25                                           

26                         Methadone

27 Methadone-Intermediate, 4-cyano-2dimethylamino-4, 4-diphenyl


1 butane

2 Moramide-Intermediate, 2-methyl-3-morpholino-1,

3 1-diphenylpropane-carboxylic acid

                                           

5                         Pethidine

6 Pethidine-Intermediate-A, 4-cyano-1-methyl-4-phenylpiperidine

7 Pethidine-Intermediate-B, ethyl-4-phenylpiperidine-4-carboxylate

8 Pethidine-Intermediate-C, 1-methyl-4-phenylpiperidine-4-

9 carboxylic acid

10                                            

11 Phenazocine                      Racemethorphan

12 Piminodine                       Racemorphan

 

 

13        (c) Unless listed in another schedule, any material,

 

14  compound, mixture, or preparation which contains any quantity of

 

15  the following substances having potential for abuse associated

 

16  with a stimulant effect on the nervous system:

 

17        (i) Amphetamine, its salts, optical isomers, and salts of its

 

18  optical isomers.

 

19        (ii) Any substance which contains any quantity of

 

20  methamphetamine, including its salts, stereoisomers, and salts of

 

21  stereoisomers.

 

22        (iii) Phenmetrazine and its salts.

 

23        (iv) Methylphenidate and its salts.

 

24        (d) Any material, compound, mixture, or preparation,

 

25  including its salts, isomers, and salts of isomers when the

 

26  existence of the salts, isomers, and salts of isomers is possible

 

27  within the specific chemical designation as listed in schedule 2,

 

28  which contains any quantity of the following substances having a


 

 1  potential for abuse associated with the depressant effect on the

 

 2  central nervous system: methaqualone, amobarbital, pentobarbital,

 

 3  or secobarbital; or, any compound, mixture, or preparation

 

 4  containing amobarbital, secobarbital, pentobarbital, or any salt

 

 5  thereof in combination with itself, with another, or with 1 or

 

 6  more other controlled substances.

 

 7        (e) Marihuana, but only for use as provided in sections 7335

 

 8  and 7336.

 

 9        Sec. 7337. As used in this section and sections 7338, 7338a,

 

10  and 7338b:

 

11        (a) "Debilitating medical condition" means 1 or more of the

 

12  following:

 

13        (i) Cancer, glaucoma, positive status for human

 

14  immunodeficiency virus, or acquired immune deficiency syndrome.

 

15        (ii) A chronic or debilitating disease or medical condition

 

16  that produces 1 or more of the following: cachexia or wasting

 

17  syndrome; severe pain; severe nausea; seizures, including those

 

18  characteristic of epilepsy; or severe and persistent muscle

 

19  spasms, including those characteristic of multiple sclerosis or

 

20  Crohn's disease.

 

21        (iii) Any other similar medical condition certified by rules

 

22  promulgated by the department.

 

23        (b) "Medical use" means the acquisition, possession,

 

24  cultivation, use, transfer, or transportation of marihuana or

 

25  paraphernalia relating to the administration of marihuana to

 

26  alleviate the symptoms or effects of a qualifying patient's

 

27  debilitating medical condition.


 

 1        (c) "Physician" means an individual licensed as a physician

 

 2  under part 170 or an osteopathic physician under part 175.

 

 3        (d) "Primary caregiver" means a person who is at least 18

 

 4  years old and who has agreed to undertake responsibility for

 

 5  managing the well-being of a person with respect to the medical

 

 6  use of marihuana.

 

 7        (e) "Qualifying patient" means a person who has been

 

 8  diagnosed by a physician as having a debilitating medical

 

 9  condition.

 

10        (f) "Written certification" means a physician's statement

 

11  under section 7338.

 

12        Sec. 7338. (1) A physician may issue to a patient who is

 

13  under his or her care a written statement certifying that, in the

 

14  physician's professional medical opinion, the patient has a

 

15  debilitating medical condition and the potential benefits of the

 

16  medical use of marihuana would likely outweigh the risk to the

 

17  patient of the medical use of marihuana. A written certification

 

18  shall not be issued under this subsection unless the physician

 

19  has made a full assessment of the patient's medical history and

 

20  medical condition, in the course of a bona fide physician-patient

 

21  relationship.

 

22        (2) A physician shall not be subject to arrest or

 

23  prosecution, penalized in any manner, or denied any right or

 

24  privilege for providing written certification under subsection

 

25  (1).

 

26        (3) Except as provided in section 7338b, a qualifying

 

27  patient who has in his or her possession a written certification


 

 1  is not subject to arrest, prosecution, or other penalty for the

 

 2  medical use of marihuana, unless the amount of marihuana

 

 3  possessed by the qualified patient and his or her primary

 

 4  caregivers exceeds the amount reasonably necessary to ensure the

 

 5  uninterrupted availability of marihuana for purposes of

 

 6  alleviating the symptoms or effects of the qualifying patient's

 

 7  debilitating medical condition or its treatment. For purposes of

 

 8  this subsection, there is a rebuttable presumption that the

 

 9  possession of 3 mature marihuana plants or 4 immature marihuana

 

10  plants, or 3 ounces of dried leaves or flowers of a marihuana

 

11  plant, does not exceed the reasonably necessary amount allowed

 

12  under this subsection.

 

13        (4) Subsection (3) does not apply to a minor under the age

 

14  of 18 years, unless all of the following apply:

 

15        (a) The minor's physician has explained the potential risks

 

16  and benefits of the medical use of marihuana to the minor and to

 

17  the minor's parent or legal guardian.

 

18        (b) The minor's parent or legal guardian of the minor

 

19  consents in writing to do all of the following:

 

20        (i) Allow the minor's medical use of marihuana.

 

21        (ii) Serve as the minor's primary caregiver.

 

22        (iii) Control the acquisition of the marihuana, the dosage,

 

23  and the frequency of the medical use of marihuana by the minor.

 

24        (5) If the acquisition, possession, cultivation,

 

25  transportation, or administration of marihuana by a qualifying

 

26  patient is not practicable, the legal protections established by

 

27  this section for a qualifying patient extend to the qualifying


 

 1  patient's primary caregivers, if the primary caregivers' actions

 

 2  are necessary for the qualifying patient's medical use of

 

 3  marihuana.

 

 4        (6) Any property or interest in property that is possessed,

 

 5  owned, or used in connection with the medical use of marihuana

 

 6  shall not be harmed, neglected, injured, or destroyed while in

 

 7  the possession of state or local law enforcement officials,

 

 8  except that law enforcement agencies seizing live plants as

 

 9  evidence are not responsible for the care and maintenance of

 

10  marihuana plants. Any such property or property interest shall

 

11  not be forfeited under state or local law providing for the

 

12  forfeiture of property other than as a sentence imposed after

 

13  conviction of a criminal offense or entry of a plea of guilty to

 

14  a criminal offense. Marihuana, marihuana paraphernalia, or other

 

15  property seized from a qualifying patient or primary caregivers

 

16  in connection with the claimed medical use of marihuana shall be

 

17  returned immediately upon the determination by a court or

 

18  prosecuting attorney that the qualifying patient or primary

 

19  caregivers are entitled to the protections of this section, as

 

20  may be evidenced by a decision not to prosecute, the dismissal of

 

21  charges, or an acquittal.

 

22        (7) A person shall not be subject to arrest or prosecution

 

23  for constructive possession, conspiracy, or any other offense for

 

24  simply being in the presence or vicinity of the medical use of

 

25  marihuana as permitted under this section.

 

26        Sec. 7338a. A person and a person's primary caregivers may

 

27  assert the medical use of marihuana as a defense to any


 

 1  prosecution involving marihuana. This defense shall be presumed

 

 2  valid if the evidence shows both of the following:

 

 3        (a) The person's medical records indicate, or a physician

 

 4  has stated that, in the physician's professional opinion, after

 

 5  having completed a full assessment of the person's medical

 

 6  history and current medical condition made in the course of a

 

 7  bona fide physician-patient relationship, the potential benefits

 

 8  of the medical use of marihuana would likely outweigh the health

 

 9  risks for the person.

 

10        (b) The person and the person's primary caregivers were

 

11  collectively in possession of a quantity of marihuana that was

 

12  not more than was reasonably necessary to ensure the

 

13  uninterrupted availability of marihuana for the purpose of

 

14  alleviating the symptoms or effects of the person's medical

 

15  condition.

 

16        Sec. 7338b. (1) The authorization for the medical use of

 

17  marihuana under sections 7337 to 7337a does not apply to any of

 

18  the following:

 

19        (a) The medical use of marihuana that endangers the health

 

20  or well-being of another person, such as driving or operating

 

21  heavy machinery while under the influence of marihuana.

 

22        (b) The smoking of marihuana in any of the following places:

 

23        (i) A school bus, public bus, or other public vehicle.

 

24        (ii) The workplace of one's employment.

 

25        (iii) Any school grounds.

 

26        (iv) Any correctional facility.

 

27        (v) Any public park, public beach, public recreation center,


 

 1  or youth center.

 

 2        (c) The use of marihuana by a qualifying patient, primary

 

 3  caregiver, or any other person for purposes other than medical

 

 4  use permitted by sections 7337 to 7337a.

 

 5        (2) A person shall not fraudulently represent to a law

 

 6  enforcement official any fact or circumstance relating to the

 

 7  medical use of marihuana to avoid arrest or prosecution. A person

 

 8  who violates this subsection is guilty of a misdemeanor

 

 9  punishable by imprisonment for not more than 30 days or a fine of

 

10  not more than $500.00, or both.

 

11        Sec. 7403. (1) A person shall not knowingly or intentionally

 

12  possess a controlled substance, a controlled substance analogue,

 

13  or a prescription form unless the controlled substance,

 

14  controlled substance analogue, or prescription form was obtained

 

15  directly from, or pursuant to, a valid prescription or order of a

 

16  practitioner while acting in the course of the practitioner's

 

17  professional practice, or except as otherwise authorized by this

 

18  article.

 

19        (2) A person who violates this section as to:

 

20        (a) A controlled substance classified in schedule 1 or 2

 

21  that is a narcotic drug or a drug described in section

 

22  7214(a)(iv), and:

 

23        (i) Which is in an amount of 1,000 grams or more of any

 

24  mixture containing that substance is guilty of a felony

 

25  punishable by imprisonment for life or any term of years or a

 

26  fine of not more than $1,000,000.00, or both.

 

27        (ii) Which is in an amount of 450 grams or more, but less


 

 1  than 1,000 grams, of any mixture containing that substance is

 

 2  guilty of a felony punishable by imprisonment for not more than

 

 3  30 years or a fine of not more than $500,000.00, or both.

 

 4        (iii) Which is in an amount of 50 grams or more, but less than

 

 5  450 grams, of any mixture containing that substance is guilty of

 

 6  a felony punishable by imprisonment for not more than 20 years or

 

 7  a fine of not more than $250,000.00, or both.

 

 8        (iv) Which is in an amount of 25 grams or more, but less than

 

 9  50 grams of any mixture containing that substance is guilty of a

 

10  felony punishable by imprisonment for not more than 4 years or a

 

11  fine of not more than $25,000.00, or both.

 

12        (v) Which is in an amount less than 25 grams of any mixture

 

13  containing that substance is guilty of a felony punishable by

 

14  imprisonment for not more than 4 years or a fine of not more than

 

15  $25,000.00, or both.

 

16        (b) Either of the following:

 

17        (i) A substance described in section 7212(1)(g) or 7214(c)(ii)

 

18  is guilty of a felony punishable by imprisonment for not more

 

19  than 10 years or a fine of not more than $15,000.00, or both.

 

20        (ii) A controlled substance classified in schedule 1, 2, 3,

 

21  or 4, except a controlled substance for which a penalty is

 

22  prescribed in subdivision (a), (b)(i), (c), or (d), or a

 

23  controlled substance analogue is guilty of a felony punishable by

 

24  imprisonment for not more than 2 years or a fine of not more than

 

25  $2,000.00, or both.

 

26        (c) Lysergic acid diethylamide, peyote, mescaline,

 

27  dimethyltryptamine, psilocyn, psilocybin, or a controlled


 

 1  substance classified in schedule 5 is guilty of a misdemeanor

 

 2  punishable by imprisonment for not more than 1 year or a fine of

 

 3  not more than $2,000.00, or both.

 

 4        (d) Marihuana is guilty of a misdemeanor punishable by

 

 5  imprisonment for not more than 1 year or a fine of not more than

 

 6  $2,000.00, or both.

 

 7        (e) A prescription form is guilty of a misdemeanor

 

 8  punishable by imprisonment for not more than 1 year or a fine of

 

 9  not more than $1,000.00, or both.

 

10        (3) If an individual was sentenced to lifetime probation

 

11  under subsection (2)(a)(iv) before the effective date of the

 

12  amendatory act that added this subsection April 1, 2003 and the

 

13  individual has served 5 or more years of that probationary

 

14  period, the probation officer for that individual may recommend

 

15  to the court that the court discharge the individual from

 

16  probation. If an individual's probation officer does not

 

17  recommend discharge as provided in this subsection, with notice

 

18  to the prosecutor, the individual may petition the court seeking

 

19  resentencing under the court rules. The court may discharge an

 

20  individual from probation as provided in this subsection. An

 

21  individual may file more than 1 motion seeking resentencing under

 

22  this subsection.

 

23        (4) This section does not apply to the medical use of

 

24  marihuana allowed under sections 7337 to 7338b.

 

25        Sec. 7404. (1) A person shall not use a controlled substance

 

26  or controlled substance analogue unless the substance was

 

27  obtained directly from, or pursuant to, a valid prescription or


 

 1  order of a practitioner while acting in the course of the

 

 2  practitioner's professional practice, or except as otherwise

 

 3  authorized by this article.

 

 4        (2) A person who violates this section as to:

 

 5        (a) A controlled substance classified in schedule 1 or 2 as

 

 6  a narcotic drug or a drug described in section 7212(1)(g) or

 

 7  7214(a)(iv) or (c)(ii) is guilty of a misdemeanor punishable by

 

 8  imprisonment for not more than 1 year or a fine of not more than

 

 9  $2,000.00, or both.

 

10        (b) A controlled substance classified in schedule 1, 2, 3,

 

11  or 4, except a controlled substance for which a penalty is

 

12  prescribed in subdivision (a), (c), or (d), or a controlled

 

13  substance analogue, is guilty of a misdemeanor punishable by

 

14  imprisonment for not more than 1 year or a fine of not more than

 

15  $1,000.00, or both.

 

16        (c) Lysergic acid diethylamide, peyote, mescaline,

 

17  dimethyltryptamine, psilocyn, psilocybin, or a controlled

 

18  substance classified in schedule 5, is guilty of a misdemeanor

 

19  punishable by imprisonment for not more than 6 months or a fine

 

20  of not more than $500.00, or both.

 

21        (d) Marihuana, is guilty of a misdemeanor punishable by

 

22  imprisonment for not more than 90 days or a fine of not more than

 

23  $100.00, or both.

 

24        (3) This section does not apply to the medical use of

 

25  marihuana allowed under sections 7337 to 7338b.

 

26        Enacting section 1. Sections 7335 and 7336 of the public

 

27  health code, 1978 PA 368, MCL 333.7335 and 333.7336, are


 

 1  repealed.